Home/Filings/4/A/0001209191-14-019903
4/A//SEC Filing

AUXILIUM PHARMACEUTICALS INC 4/A

Accession 0001209191-14-019903

CIK 0001182129operating

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 5:11 PM ET

Size

7.3 KB

Accession

0001209191-14-019903

Insider Transaction Report

Form 4/AAmended
Period: 2013-02-07
JOBES ELIZABETH VARKI
Chief Compliance Officer
Transactions
  • Award

    Common Stock

    2013-02-07+6,0009,000 total
  • Award

    Common Stock

    2014-02-18+5,50018,124 total
Footnotes (2)
  • [F1]Footnote No. 1 in the Form 4 originally filed on February 11, 2013 contained an error regarding the vesting schedule of the restricted stock units awarded to reporting person. Footnote No. 1 is hereby corrected as follows: The restricted stock units vest in 3 installments as follows: 33.33% on March 7, 2014 and 33.33% each on February 7, 2015 and on February 7, 2016.
  • [F2]Footnote No. 3 in the Form 4 originally filed on February 20, 2014 contained an error regarding the vesting schedule of the restricted stock units awarded to reporting person. Footnote No. 3 is hereby corrected as follows: The restricted stock units vest in 3 installments as follows: 33.33% on March 18, 2015 and 33.33% each on February 18, 2016 and on February 18, 2017.

Issuer

AUXILIUM PHARMACEUTICALS INC

CIK 0001182129

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001182129

Filing Metadata

Form type
4/A
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 5:11 PM ET
Size
7.3 KB